ArticleVaccines2024

Vaccine Based on Recombinant Fusion Protein Combining Hepatitis B Virus PreS with SARS-CoV-2 Wild-Type- and Omicron-Derived Receptor Binding Domain Strongly Induces Omicron-Neutralizing Antibodies in a Murine Model.

Pia Gattinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.